SEPRAGEN CORP
NT 10-K, 1998-04-01
TOTALIZING FLUID METERS & COUNTING DEVICES
Previous: JONES MEDICAL INDUSTRIES INC /DE/, PRE 14A, 1998-04-01
Next: LEVEL 3 COMMUNICATIONS INC, 8-A12G, 1998-04-01



                   SECURITIES AND EXCHANGE COMMISSION
                             UNITED STATES
                         Washington, D.C. 20549
                              FORM 12b-25

                       NOTIFICATION OF LATE FILING
                                                       SEC FILE NUMBER
                                                               0-25726
                                                          CUSIP NUMBER
                                                           817316 10 2
                                                           817316 11 0
                                                           817316 12 8


  (Check One):

  X   Form 10-K and Form 10-KSB     Form 20-F   Form 11-K   
       Form 10-Q and Form 10-QSB       Form N-SAR

                  For Period Ended: December 31, 1997

                              Transition Report on Form 10-K
                              Transition Report on Form 20-F
                              Transition Report on Form 11-K
                              Transition Report on Form 10-Q
                              Transition Report on Form N-SAR

       Nothing in this form shall be construed to imply that the
  Commission has verified any information contained herein.

       If the notification relates to a portion of the filing checked
  above, identify the Item(s) to which the notification relates:
  PART I - REGISTRANT INFORMATION

  Full Name of Registrant: SEPRAGEN CORPORATION

  Former Name if Applicable:

       Address of Principal Executive Office (Street and Number):
  30689 Huntwood Drive, Hayward, California 94544 
<PAGE>
  PART II-RULES 12B-25(B) AND(C)

       If the subject report could not be filed without unreasonable
  effort or expense and the registrant seeks relief pursuant to Rule
  12b-25(b), the following should be completed. (Check box if appro-
  priate)

       (a)  The reasons described in reasonable detail in Part III of
            this form could not be eliminated without unreasonable
            effort or expense.
   X   
       (b)  The subject annual report, semi-annual report, transition
            report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or
            portion thereof, will be filed on or before the fifteenth
            calendar day following the prescribed due date; or the
            subject quarterly report of transition report on Form 10-
            Q, or portion thereof will be filed on or before the
            fifth calendar day following the prescribed  due date;
            and

       (c)  The accountant's statement or other exhibit required by
            Rule 12b-25(c) has been attached if applicable.

  Part III - NARRATIVE

  Form 10-KSB, 20-F, 11-K, 10-Q, 10Q-SB, N-SAR, or the transition
       State below in reasonable detail the reasons why Form 10-K and
  report or portion thereof, could not be filed within the prescribed
  time period.

       Due to reduced staff and resources, Registrant was unable to
  complete all accounting and due diligence work for the Report.

  Part IV - OTHER INFORMATION
  (1)  Name and telephone number of person to contact in regard to
       this notification:  Vinit Saxena        (510) 476-0650

  (2)  Have all other periodic reports required under Section 13 or
       15(d) of the Securities Exchange Act of 1934 or Section 30 of
       the Investment Company Act of 1940 during the preceding 12
       months or for such shorter period that the registrant was
       required to file such report(s) been filed?  If answer is no,
       identify report(s):  Yes   X      No      

  (3)  Is it anticipated that any significant change in results of
       operations from the corresponding period for the last fiscal
       year will be reflected by the earnings statements to be in-
       cluded in the subject report or portion thereof?  Yes X  No  
       If so, attach an explanation of the anticipated change, both
       narratively and quantitatively, and, if appropriate, state the
       reasons why a reasonable estimate of the results cannot be
       made.  See attached.
<PAGE>
               (Name of Registrant specified in charter)
                          SEPRAGEN CORPORATION


  has caused this notification to be signed on its behalf by the
  undersigned hereunto duly authorized.


   Date: 3/31/98            By: /s/ Vinit Saxena

                                Vinit Saxena                  
                                President and CEO

       The form may be signed by an executive officer of the regis-
  trant or by any other duly authorized representative.  The name and
  title of the person signing the form shall be typed or printed
  beneath the signature.  If the statement is signed on behalf of the
  registrant by an authorized representative (other than an executive
  officer), evidence of the representative's authority to sign on
  behalf of the registrant shall be filed with the form.

                               ATTENTION

       Intentional misstatements or omissions of fact constitute
  Federal Criminal Violations (See 18 U.S. C. 1001).
<PAGE>
                          SEPRAGEN CORPORATION
                             BALANCE SHEET               DRAFT 3/31/98
                                 ASSETS
                                                     December 31,  
                                                  1997        1996 
  Current assets:
      Cash                                    $ 44,448   $ 217,057 
      Accounts receivable, less allowance
       for doubtful accounts of $10,298
       and $10,298 as of December 31, 1997 
       and 1996, respectively                  570,868     183,805 
      Inventories                              318,860     474,892 
      Prepaid expenses and other                97,484      12,633 
         Total current assets                1,031,660     888,387 
  Furniture and equipment, net                 276,211     388,201 
  Intangible assets                            120,165     130,837 
                                           $ 1,428,036  $1,407,425 

             LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT)

  Current liabilities:
      Accounts payable                      $  636,254   $ 196,686 
      Bridge Loan                              540,000          -- 
      Customer deposit                         310,481          -- 
      Notes payable                            225,000          -- 
      Accrued payroll and benefits             145,139     110,967
      Accrued liabilities                       92,720      67,665 
      Interest payable                          24,849          --
         Total current liabilities           1,974,443     375,318 

  Commitments (Note 9):
      Class E common stock, no par value
        --1,600,000 shares authorized; 
        1,209,894 and 1,111,961 shares 
        issued and outstanding at December 31, 
        1997 and 1996; redeemable at $.01 
        per share (Notes 10 and 11)                 --          -- 

  Shareholders' equity (deficit):
      Preferred stock, no par value
        --5,000,000 shares authorized; none
        issued and outstanding at December 31,
        1997 and 1996                               --          -- 
      Class A common stock, no par value
        --20,000,000 shares authorized; 
        2,149,155 shares issued and outstand-
        ing at December 31, 1997 and 1996    8,353,737   8,812,701 
      Class B common stock, no par value
        --2,600,000 shares authorized; 
        707,276 shares issued and 
        outstanding at December 31,
        1997 and 1996                        4,559,956   4,100,992 

      Accumulated deficit                  (13,460,100)(11,881,586)

   Total shareholders' equity(deficit)        (546,407)  1,032,107

                                           $ 1,428,036 $ 1,407,425 
<PAGE>
                          SEPRAGEN CORPORATION           DRAFT 3/31/98
                        STATEMENTS OF OPERATIONS
             for the years ended December 31, 1997 and 1996

                                                For the Years     
                                              Ended December 31,  
                                               1997          1996 
  Revenues:
      Net sales                         $ 1,619,623    $1,002,562 
  Costs and expenses:
      Cost of goods sold                    892,225       840,593 
      Selling, general, and 
        administrative                    1,504,481     2,344,273 
      Research and development              861,455     1,487,231 
        Total costs and expenses          3,258,161     4,672,097 
        Loss from operations             (1,638,538)   (3,669,535)
                                                        
  Interest income 
      and other, net                         60,024        90,486 
        Net loss                        $(1,578,514)  $(3,579,049)

  Net loss per common and common
    equivalent share (Note 1)           $     (0.55)  $     (1.25)

  Weighted average shares 
    outstanding (Note 1)                  2,856,431     2,856,431 
<PAGE>
                                                         DRAFT 3/31/98
      The following table is included as an aid to understanding the
  Company's operating results.  The table sets forth the percentages
  which each item bears to revenues and the percentage change in
  dollar amounts from year to year.

                                    Percentage           Year to Year
                                  Relationship
                                   to Revenues
                                                   Increase(Decrease)
                                                            
                                                           Percentage
                                  % of    % of          Year     Year
                              Revenues    Revs         Ended    Ended
  Account Name                    1997    1996          1997     1996

  Revenues                       100%    100%           62%      (4)% 
  Cost and Expenses
    Cost of goods sold
    Selling, general and          55%     84%            6%     (23)%
      administrative              93%    234%          (36)%      3% 
    Research and 
      development                 53%    148%          (42)%     38% 
      Total costs and
        expenses                 201%    466%          (30)%     16% 
  Loss from operations          (101)%  (366)%         (55)%     22% 
  Interest income 
    and other, net                 4%      9%          (34)%     59% 
  Net loss                       (97)%  (357)%         (56)%     23% 



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission